Clinical Trial Update: Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma [NA]

View source ↗

Summary

An implantable microdevice trial for delivering drugs to tumors in patients with metastatic or recurrent sarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Sarcoma, Recurrent Sarcoma | NA | Status: RECRUITING